European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing
Name	European Committee on Antimicrobial Susceptibility Testing
Founded	0 1997
Focus	Antimicrobial resistance, Antibiotic susceptibility testing
Headquarters	Basel, Switzerland
Key people	Gunnar Kahlmeter (Chair)
Parent organization	European Society of Clinical Microbiology and Infectious Diseases
Website	http://www.eucast.org

European Committee on Antimicrobial Susceptibility Testing. It is a standing committee of the European Society of Clinical Microbiology and Infectious Diseases dedicated to standardizing Antibiotic susceptibility testing across Europe. Established to combat the growing threat of Antimicrobial resistance, it provides definitive breakpoints and guidance used by clinical laboratories, researchers, and public health agencies. Its work is fundamental to guiding effective Antimicrobial chemotherapy and supporting Antimicrobial stewardship programs globally.

History and establishment

The committee was formally founded in 1997, emerging from the collaborative efforts of leading microbiologists across Europe who recognized the urgent need for harmonized Antibiotic testing standards. This initiative was a response to the disparate methodologies employed by national committees, such as the British Society for Antimicrobial Chemotherapy and the Comité de l'Antibiogramme de la Société Française de Microbiologie. Key figures in its formation included experts from institutions like the University of Gothenburg and the Robert Koch Institute. Its establishment was significantly supported by the European Society of Clinical Microbiology and Infectious Diseases, which provided an essential organizational framework and platform for international cooperation.

Mission and objectives

The primary mission is to standardize methodologies for determining Antimicrobial susceptibility of pathogens to ensure reliable and comparable results across different laboratories and countries. A core objective is to establish, review, and disseminate clinical breakpoints through a rigorous, evidence-based process. The committee also aims to educate medical professionals on best practices in Antibiotic susceptibility testing and to support the surveillance of Antimicrobial resistance trends. This work directly informs treatment guidelines and public health policies developed by bodies like the World Health Organization and the European Centre for Disease Prevention and Control.

Structure and governance

The committee operates under the auspices of the European Society of Clinical Microbiology and Infectious Diseases, with its secretariat based in Basel, Switzerland. Governance is led by an elected Executive Committee, which includes a Chair, such as Gunnar Kahlmeter, and representatives from various national committees. Its work is carried out by specialized subcommittees focusing on areas like Antifungal susceptibility testing, Disk diffusion methodology, and Antimicrobial susceptibility testing of veterinary pathogens. This structure facilitates collaboration with partner organizations like the Clinical and Laboratory Standards Institute in the United States and the Food and Drug Administration.

Breakpoint setting process

The process for setting breakpoints is a cornerstone of its work, involving systematic review of microbiological, pharmacological, and clinical data. This includes analysis of Minimum inhibitory concentration distributions, Pharmacokinetics and Pharmacodynamics studies, and outcomes from clinical trials. Expert subcommittees evaluate data on specific drug-bug combinations, such as Ceftazidime/avibactam against Pseudomonas aeruginosa or Voriconazole against Aspergillus species. Proposals are subjected to public consultation before final ratification, ensuring transparency and incorporating feedback from the global scientific community, including researchers from institutions like the Centers for Disease Control and Prevention.

Standards and guidelines

The committee publishes definitive standards, most notably the EUCAST breakpoint tables, which are updated annually and freely available. It provides detailed methodologies for Disk diffusion testing and determination of Minimum inhibitory concentration using Broth microdilution techniques. Additional guidelines cover specific challenging areas, such as susceptibility testing of Mycobacterium tuberculosis, Anaerobic bacteria, and Fastidious organisms like Streptococcus pneumoniae. These documents serve as essential references for clinical laboratories worldwide and are integrated into the protocols of surveillance networks like the European Antimicrobial Resistance Surveillance Network.

Impact and collaboration

Its standards have been adopted across Europe and in many other regions, significantly improving the consistency and quality of Antimicrobial resistance data. This harmonization is critical for meaningful global surveillance and for tracking the spread of resistant clones, such as Methicillin-resistant Staphylococcus aureus and Carbapenem-resistant Enterobacteriaceae. The committee maintains vital collaborations with the Clinical and Laboratory Standards Institute, working towards global harmonization of breakpoints. It also partners with major public health entities, including the World Health Organization and the European Medicines Agency, to influence treatment guidelines and drug development strategies against multidrug-resistant pathogens.

Category:Medical and health organizations based in Europe Category:Microbiology organizations Category:Antimicrobial resistance